MIDAZOLAM INJECTION USP

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: b927f046c6e79824
Drug Approval Canada Name: MIDAZOLAM INJECTION USP
Product Name: MIDAZOLAM INJECTION USP
Status: Marketed
Status Date: 2017-10-25
Original Market Date: 2016-06-15
Din: 02382377
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous , Intramuscular
Schedule: Targeted (CDSA IV)
Ahfs: 28:24.08
Atc Original: N05CD08 MIDAZOLAM
Atc Name: n 05 cd 08
Aig Number: 0119935002
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

MIDAZOLAM

1 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b927f046c6e79824

Type

Standard